Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Following are six reasons why pharmaceutical and life sciences companies must prioritize track-and-trace technology in their ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

The pharmaceutical industry faces significantly longer lead times than other industries, and time delays can seriously impact the health outcomes of countless individuals. Recognizing the potential ...

Ron Lanton, Partner, Lanton Law, examines the legal and economic impacts of reciprocal tariffs on the pharma supply chain, including potential disruptions and increased drug costs.

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

Widespread integration of machine learning (ML) into supply chain management by major pharma suppliers is just a few years ...

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...

Global Pharma Distributor, a leading provider of pharmaceutical distribution solutions, is building a new era in emergency ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

GSK’s global supply chain is intricate, involving both primary (active pharmaceutical ingredients manufacturing) and secondary (finished product creation) locations. Therefore, the first challenge was ...